We are monitoring the impact of COVID-19 & Recession alarm on APAC Genetic Testing Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Genetic Testing Market Research Report – Segmented By Type, Application and Country (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 23
Pages: 137

Asia Pacific Genetic Testing Market Size (2022 to 2027)

The size of the Genetic Testing Market in the Asia Pacific was worth USD 10.60 billion in 2022 and is forecasted to reach USD 15.33 billion by 2027 growing at a CAGR of 7.65% during the forecast period.

As the need to provide superior healthcare due to advancements in healthcare is increasing, genetic testing has become a highly attractive segment in the molecular diagnostics market. The slightest modifications with the inherited disease condition like chromosomes, genes, or proteins can be identified through genetic testing. Genetic testing, which is an analysis of genes, chromosomes, or proteins, helps predict the risk of diseases, its diagnosis, likely course of the disease, and identifying carriers (individuals not having the disease but have a copy of the disease gene) of disease. Genetic testing has also helped easily diagnose diseases like sickle cell anemia, hemophilia, and cystic fibrosis and helping patients living a normal life.

A few of the significant factors promoting the APAC genetic testing market are the growing awareness among individuals regarding the potential benefits of genetic testing. In addition, advancements and huge investments in the genetic testing space, a growing aging population and a rise in the number of chronic diseases, and increasing cancer cases are the other factors aiding the growth in the genetic testing market.

Cancer genetic testing is estimated to witness high growth and is most likely to accelerate the growth rate of the genetic testing market in this region during the forecast period. The market for screening newborns, diagnosing rare and fatal disorders, and estimating the probability of diseases is likely to expand. Particularly, genetic tests to screen newborns are expected to expand immensely in the future. The growing frequency of genetic diseases unravels new opportunities for genetic testing and its related applications. It is anticipated that the transformation of genetic testing from a service-driven market to a product-driven market will push the diagnostic companies to expand their operations.

However, few factors affect the growth of the genetic testing market, like the authenticity of genetic reports being questioned due to a lack of credible standard procedure. And also, many individuals are concerned about the high cost associated with testing.

This research report on the APAC Genetic Testing Market has been segmented and sub-segmented into the following categories:

By Application: 

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

By Test: 

  • Carrier Testing
  • Diagnostic Testing
  • Prenatal Testing
  • Neonatal Testing

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

Geographically, the Indian genetic testing market is the fastest-growing country in the Asia Pacific market due to various diseases and development in the healthcare sector. 

The Chinese genetic testing market has the largest growth in the APAC market due to rising genetic disorders in China. Recently, the China government has taken the initiative in genetic science development. 

The Japanese genetic testing market is expected to grow at a healthy rate in the coming years. Life sciences companies focus on a screening test for cancer and the introduction of DNA testing in Japan and South Korea, driving the demand for the genetic testing market.

The contract research organization (CRO) PPD and Neo genomic are specialized for cancer genetic testing, and it started new laboratory services in Singapore for clinical trials. Also, development in healthcare sectors and implementation of innovative techniques in the Singapore genetic testing market foresee growth in Asia-Pacific.


A few of the prominent companies dominating the APAC Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.


                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 China            

                6.3 India              

                6.4 Japan            

                6.5 South Korea

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 


                a) List of Tables

                b) List of Figures              

  1. Asia-Pacific Genetic Testing Market By Region, From 2022 - 2027 (USD Billion)
  2. Asia-Pacific Genetic Testing Market By Type, From 2022 - 2027 (USD Billion)
  3. Asia-Pacific Carrier Testing Market By Region, From 2022 - 2027 (USD Billion)
  4. Asia-Pacific Diagnostic Testing Market By Region, From 2022 - 2027 (USD Billion)
  5. Asia-Pacific Prenatal Testing Market By Region, From 2022 - 2027 (USD Billion)
  6. Asia-Pacific Neonatal Testing Market By Region, From 2022 - 2027 (USD Billion)
  7. Asia-Pacific Genetic Testing Market By Application, From 2022 - 2027 (USD Billion)
  8. Asia-Pacific Cancer Testing Market By Region, From 2022 - 2027 (USD Billion)
  9. Asia-Pacific Prenatal Testing Market By Region, From 2022 - 2027 (USD Billion)
  10. Asia-Pacific Pharmacogenomics Testing Market By Region, From 2022 - 2027 (USD Billion)
  11. Asia-Pacific Predisposition Testing Market By Region, From 2022 - 2027 (USD Billion)
  12. China Genetic Testing Market By Type, From 2022 - 2027 (USD Billion)
  13. China Genetic Testing Market By Application, From 2022 - 2027 (USD Billion)
  14. India Genetic Testing Market By Type, From 2022 - 2027 (USD Billion)
  15. India Genetic Testing Market By Application, From 2022 - 2027 (USD Billion)
  16. Japan Genetic Testing Market By Type, From 2022 - 2027 (USD Billion)
  17. Japan Genetic Testing Market By Application, From 2022 - 2027 (USD Billion)
  18. South Korea Genetic Testing Market By Type, From 2022 - 2027 (USD Billion)
  19. South Korea Genetic Testing Market By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample